↓ Skip to main content

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment

Overview of attention for article published in Frontiers in Cardiovascular Medicine, September 2020
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (68th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

twitter
7 X users

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
32 Mendeley
Title
QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment
Published in
Frontiers in Cardiovascular Medicine, September 2020
DOI 10.3389/fcvm.2020.00152
Pubmed ID
Authors

Sarah Grewal, Lior Jankelson, Marcel P. H. van den Broek, Martin Cour, Gloria Bachmann, John B. Kostis, Kamana Misra

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Other 5 16%
Student > Bachelor 4 13%
Researcher 4 13%
Student > Postgraduate 2 6%
Student > Ph. D. Student 2 6%
Other 6 19%
Unknown 9 28%
Readers by discipline Count As %
Medicine and Dentistry 10 31%
Pharmacology, Toxicology and Pharmaceutical Science 5 16%
Unspecified 1 3%
Nursing and Health Professions 1 3%
Agricultural and Biological Sciences 1 3%
Other 5 16%
Unknown 9 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 September 2020.
All research outputs
#5,830,497
of 23,221,875 outputs
Outputs from Frontiers in Cardiovascular Medicine
#891
of 7,128 outputs
Outputs of similar age
#125,417
of 399,709 outputs
Outputs of similar age from Frontiers in Cardiovascular Medicine
#17
of 66 outputs
Altmetric has tracked 23,221,875 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 7,128 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 399,709 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.
We're also able to compare this research output to 66 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.